Radius Health Inc.: Radius Health Announces Clinical Collaboration With a …

Radius Health Inc.: Radius Health Announces Clinical Collaboration With a …

RAD1901 is a selective estrogen receptor down-regulator/degrader, or SERD, which at high doses has potential for use as an oral non-steroidal treatment for hormone-driven, or hormone-resistant, metastatic breast cancer. RAD1901 is currently being …

(Visited 1 times, 1 visits today)
5
Like
Save

Comments

Comments are disabled for this post.